{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:44:28Z","timestamp":1760147068432,"version":"build-2065373602"},"reference-count":42,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian MUR","award":["POC01_00072","GGP15083","AIM1893457"],"award-info":[{"award-number":["POC01_00072","GGP15083","AIM1893457"]}]},{"name":"TELETHON Foundation","award":["POC01_00072","GGP15083","AIM1893457"],"award-info":[{"award-number":["POC01_00072","GGP15083","AIM1893457"]}]},{"name":"Attraction and International Mobility","award":["POC01_00072","GGP15083","AIM1893457"],"award-info":[{"award-number":["POC01_00072","GGP15083","AIM1893457"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>We previously reported the novel finding that \u03b23-AR is functionally expressed in the renal tubule and shares its cellular localization with the vasopressin receptor AVPR2, whose physiological stimulation triggers antidiuresis by increasing the plasma membrane expression of the water channel AQP2 and the NKCC2 symporter in renal cells. We also showed that pharmacologic stimulation of \u03b23-AR is capable of triggering antidiuresis and correcting polyuria, in the knockout mice for the AVPR2 receptor, the animal model of human X-linked nephrogenic diabetes insipidus (XNDI), a rare genetic disease still missing a cure. Here, to demonstrate that the same response can be evoked in humans, we evaluated the effect of treatment with the \u03b23-AR agonist mirabegron on AQP2 and NKCC2 trafficking, by evaluating their urinary excretion in a cohort of patients with overactive bladder syndrome, for the treatment of which the drug is already approved. Compared to baseline, treatment with mirabegron significantly increased AQP2 and NKCC2 excretion for the 12 weeks of treatment. This data is a step forward in corroborating the hypothesis that in patients with XNDI, treatment with mirabegron could bypass the inactivation of AVPR2, trigger antidiuresis and correct the dramatic polyuria which is the main hallmark of this disease.<\/jats:p>","DOI":"10.3390\/ijms24021136","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T01:36:17Z","timestamp":1673228177000},"page":"1136","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["\u03b23 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Diabetes Insipidus"],"prefix":"10.3390","volume":"24","author":[{"given":"Serena","family":"Milano","sequence":"first","affiliation":[{"name":"Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari, 70125 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Maqoud","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari, 70125 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Rutigliano","sequence":"additional","affiliation":[{"name":"Urology, Andrology and Kidney Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilenia","family":"Saponara","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari, 70125 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Carmosino","sequence":"additional","affiliation":[{"name":"Department of Science, University of Potenza, 85100 Potenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2839-0130","authenticated-orcid":false,"given":"Andrea","family":"Gerbino","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari, 70125 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7807-1229","authenticated-orcid":false,"given":"Giuseppe","family":"Lucarelli","sequence":"additional","affiliation":[{"name":"Urology, Andrology and Kidney Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Battaglia","sequence":"additional","affiliation":[{"name":"Urology, Andrology and Kidney Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Svelto","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari, 70125 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0043-7523","authenticated-orcid":false,"given":"Giuseppe","family":"Procino","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari, 70125 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.kint.2016.03.020","article-title":"Beta3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function","volume":"90","author":"Procino","year":"2016","journal-title":"Kidney Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.kint.2016.04.013","article-title":"Beta3-Adrenoreceptors in the thick ascending limb of Henle and in principal cells of the collecting duct work to concentrate urine","volume":"90","author":"Bichet","year":"2016","journal-title":"Kidney Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/357333a0","article-title":"Molecular cloning of the receptor for human antidiuretic hormone","volume":"357","author":"Birnbaumer","year":"1992","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/357336a0","article-title":"Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus","volume":"357","author":"Lolait","year":"1992","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1073\/pnas.92.4.1013","article-title":"Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane","volume":"92","author":"Nielsen","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","first-page":"22","article-title":"The selectivity in vitro of the stereoisomers of the beta-3 adrenoceptor agonist BRL 37344","volume":"277","author":"Oriowo","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-physiol-021113-170350","article-title":"Advances in understanding the urine-concentrating mechanism","volume":"76","author":"Sands","year":"2014","journal-title":"Annu. Rev. Physiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1172\/JCI39680","article-title":"A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus","volume":"119","author":"Li","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Milano, S., Carmosino, M., Gerbino, A., Svelto, M., and Procino, G. (2017). Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18112385"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1159\/000491916","article-title":"Human beta3-Adrenoreceptor is Resistant to Agonist-Induced Desensitization in Renal Epithelial Cells","volume":"48","author":"Milano","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/nau.22505","article-title":"Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability","volume":"33","author":"Chapple","year":"2014","journal-title":"Neurourol. Urodyn."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/1756287212457114","article-title":"Mirabegron: A review of recent data and its prospects in the management of overactive bladder","volume":"4","author":"Sacco","year":"2012","journal-title":"Ther. Adv. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/2042098616659412","article-title":"Mirabegron in overactive bladder patients: Efficacy review and update on drug safety","volume":"7","author":"Warren","year":"2016","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1124\/jpet.106.115840","article-title":"Effect of (R)-2-(2-aminothiazol-4-yl)-4\u2019-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function","volume":"321","author":"Takasu","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1681\/ASN.V73403","article-title":"Urinary excretion of aquaporin-2 in humans: A potential marker of collecting duct responsiveness to vasopressin","volume":"7","author":"Elliot","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/ki.2011.251","article-title":"Renal tubular dysfunction in patients with American cutaneous leishmaniasis","volume":"80","author":"Oliveira","year":"2011","journal-title":"Kidney Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1681\/ASN.V1071416","article-title":"Urinary excretion of aquaporin-2 in rat is mediated by a vasopressin-dependent apical pathway","volume":"10","author":"Wen","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/pmic.201200285","article-title":"Urinary exosomes: A reservoir for biomarker discovery and potential mediators of intrarenal signalling","volume":"13","author":"Dear","year":"2013","journal-title":"Proteomics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"695824","DOI":"10.3389\/fphys.2021.695824","article-title":"Activation of the Thiazide-Sensitive Sodium-Chloride Cotransporter by Beta3-Adrenoreceptor in the Distal Convoluted Tubule","volume":"12","author":"Milano","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1091\/mbc.e10-05-0456","article-title":"MAL\/VIP17, a new player in the regulation of NKCC2 in the kidney","volume":"21","author":"Carmosino","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.ackd.2006.01.006","article-title":"Nephrogenic diabetes insipidus","volume":"13","author":"Bichet","year":"2006","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1006\/bbrc.1993.1705","article-title":"Type 2 vasopressin receptor gene, the gene responsible nephrogenic diabetes insipidus, maps to Xq28 close to the LICAM gene","volume":"193","author":"Frattini","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s004670100051","article-title":"Molecular and cellular defects in nephrogenic diabetes insipidus","volume":"16","author":"Knoers","year":"2001","journal-title":"Pediatr. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1210\/er.2012-1044","article-title":"Nephrogenic diabetes insipidus: Essential insights into the molecular background and potential therapies for treatment","volume":"34","author":"Moeller","year":"2013","journal-title":"Endocr. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.1016\/S0021-9258(19)38614-4","article-title":"Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase","volume":"268","author":"Rosenthal","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/359233a0","article-title":"Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus","volume":"359","author":"Rosenthal","year":"1992","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s00467-012-2118-8","article-title":"Congenital nephrogenic diabetes insipidus: The current state of affairs","volume":"27","author":"Wesche","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.urology.2013.02.077","article-title":"A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the beta(3) adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder","volume":"82","author":"Herschorn","year":"2013","journal-title":"Urology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.juro.2012.10.017","article-title":"Results of a randomized phase III trial of mirabegron in patients with overactive bladder","volume":"189","author":"Nitti","year":"2013","journal-title":"J. Urol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/bju.12649","article-title":"Phase III, randomised, double-blind, placebo-controlled study of the beta3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder","volume":"113","author":"Yamaguchi","year":"2014","journal-title":"BJU Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/03007995.2017.1419170","article-title":"Mirabegron improves quality-of-life, treatment satisfaction, and persistence in patients with overactive bladder: A multi-center, non-interventional, real-world, 12-month study","volume":"34","author":"Freeman","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nep.12005","article-title":"Exosomes and the kidney: Blaming the messenger","volume":"18","author":"Fang","year":"2013","journal-title":"Nephrology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"13368","DOI":"10.1073\/pnas.0403453101","article-title":"Identification and proteomic profiling of exosomes in human urine","volume":"101","author":"Pisitkun","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199506083322303","article-title":"Urinary excretion of aquaporin-2 in patients with diabetes insipidus","volume":"332","author":"Kanno","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"F1374","DOI":"10.1152\/ajprenal.00208.2013","article-title":"Development of enzyme-linked immunosorbent assays for urinary thiazide-sensitive Na-Cl cotransporter measurement","volume":"305","author":"Isobe","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000274468","article-title":"Are sodium transporters in urinary exosomes reliable markers of tubular sodium reabsorption in hypertensive patients?","volume":"114","author":"Wang","year":"2010","journal-title":"Nephron. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1471-2369-15-101","article-title":"Abnormal urinary excretion of NKCC2 and AQP2 in response to hypertonic saline in chronic kidney disease: An intervention study in patients with chronic kidney disease and healthy controls","volume":"15","author":"Jensen","year":"2014","journal-title":"BMC Nephrol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ki.2014.10","article-title":"Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice","volume":"86","author":"Procino","year":"2014","journal-title":"Kidney Int."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Corciulo, S., Nicoletti, M.C., Mastrofrancesco, L., Milano, S., Mastrodonato, M., Carmosino, M., Gerbino, A., Corciulo, R., Russo, R., and Svelto, M. (2019). AQP1-Containing Exosomes in Peritoneal Dialysis Effluent As Biomarker of Dialysis Efficiency. Cells, 8.","DOI":"10.3390\/cells8040330"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Piccapane, F., Gerbino, A., Carmosino, M., Milano, S., Arduini, A., Debellis, L., Svelto, M., Caroppo, R., and Procino, G. (2021). Aquaporin-1 Facilitates Transmesothelial Water Permeability: In Vitro and Ex Vivo Evidence and Possible Implications in Peritoneal Dialysis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212535"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1046\/j.1523-1755.2002.00686.x","article-title":"Comparison of three methods to quantify urinary aquaporin-2 protein","volume":"62","author":"Umenishi","year":"2002","journal-title":"Kidney Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.bbamem.2006.03.029","article-title":"Water immersion is associated with an increase in aquaporin-2 excretion in healthy volunteers","volume":"1758","author":"Valenti","year":"2006","journal-title":"Biochim. Biophys. Acta"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/2\/1136\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:01:45Z","timestamp":1760119305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/2\/1136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijms24021136"],"URL":"https:\/\/doi.org\/10.3390\/ijms24021136","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2023,1,6]]}}}